Telix Pharmaceuticals Limited (ASX: TLX)
Australia
· Delayed Price · Currency is AUD 24.74
-0.93 (-3.62%)
Dec 20, 2024, 4:10 PM AEST
Telix Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | 49.19 | 5.21 | -104.08 | -80.51 | -44.89 | -27.87 | Upgrade
|
| Depreciation & Amortization | 7.25 | 6.74 | 5.38 | 5.17 | 4.88 | 4.24 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.8 | 0.8 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 8.79 | 8.79 | 8.11 | 1.32 | 2.35 | 1.27 | Upgrade
|
| Other Operating Activities | 17.19 | 35.85 | 27.62 | 17.32 | 7.81 | -0.61 | Upgrade
|
| Change in Accounts Receivable | -27.38 | -27.38 | -19.93 | -7.19 | -0.33 | -3.64 | Upgrade
|
| Change in Inventory | -9.64 | -9.64 | -5.02 | -2.82 | -0.09 | 0.1 | Upgrade
|
| Change in Accounts Payable | 29.32 | 29.32 | 30.45 | 7.48 | 1.67 | 2.98 | Upgrade
|
| Change in Unearned Revenue | -5.29 | -5.29 | -2.82 | -2.7 | 30.75 | - | Upgrade
|
| Change in Other Net Operating Assets | -20.52 | -20.52 | -3.69 | 2.6 | -0.19 | 0.2 | Upgrade
|
| Operating Cash Flow | 49.71 | 23.88 | -63.97 | -59.33 | 1.96 | -23.33 | Upgrade
|
| Capital Expenditures | -11.36 | -9.68 | -7.04 | -1.34 | -0.25 | -0.4 | Upgrade
|
| Cash Acquisitions | -23.31 | - | -0.97 | - | -0.32 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -12.86 | -1.12 | -6.82 | - | -0.07 | -0.07 | Upgrade
|
| Investment in Securities | -15.14 | -13.16 | - | - | - | - | Upgrade
|
| Other Investing Activities | -5.77 | -1.54 | -2.16 | -1.39 | -0.45 | - | Upgrade
|
| Investing Cash Flow | -68.44 | -25.49 | -17 | -2.73 | -1.09 | -0.47 | Upgrade
|
| Long-Term Debt Issued | - | 5.76 | 3.01 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -2.22 | -1.28 | -0.94 | -0.9 | -1.17 | Upgrade
|
| Net Debt Issued (Repaid) | 3.28 | 3.53 | 1.74 | -0.94 | -0.9 | -1.17 | Upgrade
|
| Issuance of Common Stock | 4.36 | 6.65 | 181.04 | 3.78 | 35.15 | 45.25 | Upgrade
|
| Other Financing Activities | - | - | -7.82 | - | -0.13 | -1.36 | Upgrade
|
| Financing Cash Flow | 7.64 | 10.19 | 174.96 | 2.85 | 34.12 | 42.72 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.79 | -1.67 | 0.3 | 3.3 | -1.64 | -0.1 | Upgrade
|
| Net Cash Flow | -12.89 | 6.91 | 94.29 | -55.91 | 33.35 | 18.83 | Upgrade
|
| Free Cash Flow | 38.35 | 14.21 | -71.01 | -60.67 | 1.71 | -23.74 | Upgrade
|
| Free Cash Flow Margin | 5.94% | 2.83% | -44.35% | -798.67% | 32.84% | -681.09% | Upgrade
|
| Free Cash Flow Per Share | 0.11 | 0.04 | -0.23 | -0.21 | 0.01 | -0.10 | Upgrade
|
| Cash Interest Paid | 1.1 | 0.79 | 0.41 | 0.19 | 0.19 | 0.12 | Upgrade
|
| Cash Income Tax Paid | 11.18 | 10.25 | -16.63 | -12.12 | -11.41 | -9.26 | Upgrade
|
| Levered Free Cash Flow | 105.93 | 62.9 | -30.72 | -37.39 | -16.54 | -21.16 | Upgrade
|
| Unlevered Free Cash Flow | 106.49 | 63.39 | -30.52 | -37.28 | -16.43 | -21.09 | Upgrade
|
| Change in Net Working Capital | -63.96 | -26.23 | -16.17 | -8.34 | -7.45 | 0.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.